Małgorzata Pawlikowska

**Małgorzata Pawlikowska** serves as Head of the Clinical Study Department at Pure Clinical, where she is responsible for the design, coordination, and oversight of clinical investigations of medical devices (MD) and performance studies of in vitro diagnostic medical devices (IVD). She specialises in conducting projects in accordance with the requirements of MDR 2017/745, IVDR 2017/746, ISO 14155, ISO 90216, ICH GCP, FDA requirements, and other applicable regulatory requirements and quality standards. She is responsible for developing study concepts and strategies, preparing clinical study documentation, and managing clinical investigations and their reporting. She oversees the preparation and conduct of clinical investigations, performance studies, and usability studies, coordinating the work of internal teams, sponsors, research sites, and other partners involved in the projects. She ensures regulatory compliance, the quality of study documentation, and the timely execution of studies. She also supports strategic planning. She has over 16 years of experience in the scientific research sector. She completed doctoral studies in Biological Sciences and holds a Master’s degree in Biotechnology from Nicolaus Copernicus University in Toruń, as well as a postgraduate qualification in the Conduct and Monitoring of Clinical Trials from Kozminski University in Warsaw.

Małgorzata Pawlikowska

Małgorzata Pawlikowska

Head of Clinical Study Department

Education (5)

Kozminski University

Postgraduate Studies, Conducting and Monitoring of Clinical TrialsPostgraduate Studies, Conducting and Monitoring of Clinical Trials

X 2022 – VI 2023

Nicolaus Copernicus University in Toruń

Doctor of Philosophy - PhD, Biological Sciences

X 2008 – VI 2013

WSB Merito University in Toruń

Quality management

X 2009 – VI 2010

Max Planck Institute of Immunobiology and Epigenetics

InternshipInternship

IX 2007 – IV 2008

Nicolaus Copernicus University in Toruń

Master of Science - MS, BiotechnologyMaster of Science - MS, Biotechnology

X 2006 – VI 2008

Work Experience (4)

Pure Clinical

Head of Clinical Study Department

V 2025 – currently

Senior Clinical Research Scientist

II 2024 - V 2025

Clinical Research Scientist

III 2023 – II 2024

Nicolaus Copernicus University

Assistant Professor

X 2019 – II 2023

Research Assistant

I 2014 – XI 2019

Immquest Sp. z o.o.

Lab Advisor

VI 2016 – VII 2019

BPIC Sp. z o.o.

Certification Specialist

X 2011 – XII 2013

Publications (5)

Pawlikowska M et al. Fever-range hyperthermia inhibits cells immune response to protein-bound polysaccharides derived from Coriolus versicolor extract. Mol Immunol. 2016 Dec;80:50-57. doi: 10.1016/j.molimm.2016.10.013. Epub 2016 Nov 5. PMID: 27825050

Pawlikowska M et al. Protein-Bound Polysaccharides from Coriolus Versicolor Induce RIPK1/RIPK3/MLKL-Mediated Necroptosis in ER-Positive Breast Cancer and Amelanotic Melanoma Cells. Cell Physiol Biochem. 2020 Jun 13;54(4):591-604. doi: 10.33594/000000242. PMID: 32531147.

Pawlikowska M et al. Coriolus versicolor-derived protein-bound polysaccharides trigger the caspase-independent cell death pathway in amelanotic but not melanotic melanoma cells. Phytother Res. 2020 Jan;34(1):173-183. doi: 10.1002/ptr.6513. Epub 2019 Sep 12. PMID: 31515931.

Pawlikowska M et al. Pigmentation Levels Affect Melanoma Responses to Coriolus versicolor Extract and Play a Crucial Role in Melanoma-Mononuclear Cell Crosstalk. Int J Mol Sci. 2021 May 27;22(11):5735. doi: 10.3390/ijms22115735. PMID: 34072104; PMCID: PMC8198516.

Jędrzejewski T, Pawlikowska M et al. COVID-19 and Cancer Diseases-The Potential of Coriolus versicolor Mushroom to Combat Global Health Challenges. Int J Mol Sci. 2023 Mar 2;24(5):4864. doi: 10.3390/ijms24054864. PMID: 36902290; PMCID: PMC10003402.